These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8479323)

  • 21. Isolated pulmonary hypertension in the grandchild of a kindred with scleroderma (systemic sclerosis): "neonatal scleroderma"?
    Morse JH; Barst RJ; Whitman HH; Fotino M; Jacobs JC
    J Rheumatol; 1989 Dec; 16(12):1536-41. PubMed ID: 2625683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants.
    Reveille JD; Fischbach M; McNearney T; Friedman AW; Aguilar MB; Lisse J; Fritzler MJ; Ahn C; Arnett FC;
    Semin Arthritis Rheum; 2001 Apr; 30(5):332-46. PubMed ID: 11303306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic sclerosis in mother and daughter with susceptible HLA haplotype and anti-topoisomerase I autoantibodies.
    Kurteva EK; Boyadzhieva VV; Stoilov NR
    Rheumatol Int; 2020 Jun; 40(6):1001-1009. PubMed ID: 31970496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different distribution of HLA class II alleles in anti-topoisomerase I autoantibody responders between silicosis and systemic sclerosis patients, with a common distinct amino acid sequence in the HLA-DQB1 domain.
    Ueki A; Isozaki Y; Tomokuni A; Ueki H; Kusaka M; Tanaka S; Otsuki T; Sakaguchi H; Hyodoh F
    Immunobiology; 2001 Dec; 204(4):458-65. PubMed ID: 11776400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MHC class II associations with autoantibody and T cell immune responses to the scleroderma autoantigen topoisomerase I.
    Rands AL; Whyte J; Cox B; Hall ND; McHugh NJ
    J Autoimmun; 2000 Dec; 15(4):451-8. PubMed ID: 11090244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and immunological differences between Japanese patients with diffuse scleroderma and limited scleroderma.
    Satoh M; Akizuki M; Kuwana M; Mimori T; Yamagata H; Yoshida S; Homma M; Yamamoto T; Sasazuki T
    J Rheumatol; 1994 Jan; 21(1):111-4. PubMed ID: 8151564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA and autoimmunity in scleroderma (systemic sclerosis).
    Arnett FC
    Int Rev Immunol; 1995; 12(2-4):107-28. PubMed ID: 7650416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial systemic lupus erythematosus: immunogenetic studies in eight families.
    Reveille JD; Bias WB; Winkelstein JA; Provost TT; Dorsch CA; Arnett FC
    Medicine (Baltimore); 1983 Jan; 62(1):21-35. PubMed ID: 6600509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies to a nucleolar RNA helicase protein in patients with connective tissue diseases.
    Arnett FC; Reveille JD; Valdez BC
    Arthritis Rheum; 1997 Aug; 40(8):1487-92. PubMed ID: 9259430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic sclerosis in German uranium miners under special consideration of autoantibody subsets and HLA class II alleles.
    Baur X; Rihs HP; Altmeyer P; Degens P; Conrad K; Mehlhorn J; Weber K; Wiebe V
    Respiration; 1996; 63(6):368-75. PubMed ID: 8933656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy.
    Rider LG; Gurley RC; Pandey JP; Garcia de la Torre I; Kalovidouris AE; O'Hanlon TP; Love LA; Hennekam RC; Baumbach LL; Neville HE; Garcia CA; Klingman J; Gibbs M; Weisman MH; Targoff IN; Miller FW
    Arthritis Rheum; 1998 Apr; 41(4):710-9. PubMed ID: 9550481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency.
    Frezza D; Giambra V; Tolusso B; De Santis M; Bosello S; Vettori S; Triolo G; Valentini G; Ferraccioli G
    Ann Rheum Dis; 2007 Sep; 66(9):1210-5. PubMed ID: 17392350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies against antigens related to scleroderma in a cohort of patients with morphea.
    Arisi M; Cavazzana I; Cerutti ME; Ferrari F; Carabellese N; Rossi MT; Tincani A; Calzavara-Pinton P; Franceschini F
    G Ital Dermatol Venereol; 2018 Aug; 153(4):451-458. PubMed ID: 27706114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.
    Zhou X; Lee JE; Arnett FC; Xiong M; Park MY; Yoo YK; Shin ES; Reveille JD; Mayes MD; Kim JH; Song R; Choi JY; Park JA; Lee YJ; Lee EY; Song YW; Lee EB
    Arthritis Rheum; 2009 Dec; 60(12):3807-14. PubMed ID: 19950302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.
    Vlachoyiannopoulos PG; Dafni UG; Pakas I; Spyropoulou-Vlachou M; Stavropoulos-Giokas C; Moutsopoulos HM
    Ann Rheum Dis; 2000 May; 59(5):359-67. PubMed ID: 10784518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial Sjögren's syndrome in the Japanese: immunogenetic and serological studies.
    Moriuchi J; Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Sato K; Tsuji K; Arimori S
    Clin Exp Rheumatol; 1986; 4(3):237-41. PubMed ID: 3769241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders.
    Reitamo S; Remitz A; Varga J; Ceska M; Effenberger F; Jimenez S; Uitto J
    Arch Dermatol; 1993 Feb; 129(2):189-93. PubMed ID: 8434976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.